Executive Director's Purchase Signals Potential Confidence at Processa Pharmaceuticals
Patrick Lin, Chief Business and Strategy Officer of Processa Pharmaceuticals, Inc. (PCSA), recently purchased additional common stock, an action that some analysts interpret as a reflection of internal confidence. The acquisition occurred while the company's stock was trading close to its recent low point.